共 27 条
- [1] Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997 [J]. LEUKEMIA RESEARCH, 2006, 30 (07) : 823 - 827